Levine, R L <br/><br/>
KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).  [electronic resource] 

 -  Leukemia  Jan 2005 
 - 27-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2403548  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amino Acid Sequence<br/>Antineoplastic Agents--therapeutic use<br/>Base Sequence<br/>Benzamides<br/>Chromosomes, Human, Pair 14<br/>Chromosomes, Human, Pair 5<br/>Cloning, Molecular<br/>DNA Primers<br/>Humans<br/>Imatinib Mesylate<br/>In Situ Hybridization, Fluorescence<br/>Male<br/>Myeloproliferative Disorders--drug therapy<br/>Piperazines--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Receptor, Platelet-Derived Growth Factor beta--genetics<br/>Translocation, Genetic